Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Philippines Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20064
20071
20082
20094
20102
20111
20153
20161
20172
20186
20192
20202
20211
20222
20235
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting12
Terminated5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Merck Sharp & Dohme LLC6
Boehringer Ingelheim3
Genzyme, a Sanofi Company3
Novartis Pharmaceuticals2
Agennix1
Amgen1
ArriVent BioPharma, Inc.1
Bayer1
Bioven Europe1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung45
Lung Neoplasms7
Carcinoma5
Neoplasm Metastasis3
Adenocarcinoma2
Adenocarcinoma of Lung2
Neoplasms2
Anemia1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.